LBR

Across TCGA pan-cancer cohorts, LBR Mutation is linked to patient survival in 8 of 34 cancer types, making it a survival-associated LBR data layer compared with 28 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LBR Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LBR expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

BRCA, SKCM, and KIRP are the cancer types where LBR Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.653	0.924	.005	10	view →
SKCM	OS	Median	All	0.174	0.781	<.001	9	view →
KIRP	DFS	Median	All	0.218	0.771	.029	6	view →
BLCA	DFS	Median	III,IV	0.152	0.572	.031	6	view →
SCLC	OS	Median	All	0.219	0.706	.011	6	view →
ESCA	OS	Median	All	0.176	0.700	.006	6	view →
LUSC	OS	Median	All	0.196	0.724	.049	3	view →
UCEC	DFS	Median	All	0.949	0.624	.046	2	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

LBR–BRCA (OS)

Open the BRCA breakdown →